This inventor holds 1 USPTO granted patent. Top assignee: Cancer Research Technology Limited. Active years: 2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2026
Title: Marcel Deken and His Patent on Anti-CD73 Antibodies.
Introduction
Marcel Deken is an inventor associated with Geneva, Switzerland. His patent work includes an invention titled “Anti-CD73 Antibodies.”
Latest Patents
Deken is listed as an inventor on 1 patent: “Anti-CD73 Antibodies.” The title indicates a focus on antibodies targeting CD73.
Career Highlights
Deken is associated with Cancer Research Technology Limited. The available information identifies his contribution to the anti-CD73 antibody patent but does not provide further details about his role or career history.
Collaborations
Grainne Gernon is identified as Deken’s coworker. The provided information does not specify her role in the patent or their collaboration.
Conclusion
Marcel Deken’s recorded patent activity includes an anti-CD73 antibody invention and an association with Cancer Research Technology Limited.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile